IDEAS home Printed from https://ideas.repec.org/a/pal/palcom/v4y2018i1d10.1057_s41599-018-0181-x.html
   My bibliography  Save this article

The evolving response to antibiotic resistance (1945–2018)

Author

Listed:
  • Scott H. Podolsky

    (Harvard Medical School)

Abstract

The intensity and character of concerns about antibiotic resistance, over the past nearly seventy-five years, have depended on a series of linked factors: the evolution and distribution of resistant microbes themselves; our differential capacity and efforts to detect such microbes; evolving models of antibiotic resistance and the related projected impact of antibiotic resistance on medical, social, and economic futures; the linkages of antibiotic prescribing and usage to the prevailing practice and identities of the medical and veterinary professions, and to the practice of agribusiness; the projected capacity of biomedicine (and especially the pharmaceutical industry) to stay ahead of such developing resistance; the perceived global context in which such resistance has developed; and the coordination of efforts and the development of infrastructure and funding to draw attention to and confront such microbial resistance. This paper traces the evolving response to antibiotic resistance through what at this point appear to be five eras: that between 1945 and 1963, a relatively optimistic period during which time the pharmaceutical industry appeared to most as capable of keeping up with antibiotic resistance; that between 1963 and 1981, characterized by increasing concern (though limited reformist activity) in the wake of the discovery of the transmission of antibiotic resistance via extrachromosomal plasmids; that between 1981 and 1992, notable for the explicit framing of antibiotic resistance as a shared global problem by such reformers as Stuart Levy and the Alliance for the Prudent Use of Antibiotics; that from 1992 through 2013, during which time antibiotic resistance became linked to larger concerns regarding emerging infections and received increasing collective attention and funding; and that from 2013 through to the present, with antibiotic resistance still more palpably and publicly embedded within larger concerns over global emerging infections, social justice, and development goals, attracting interest from a diverse cohort of actors.

Suggested Citation

  • Scott H. Podolsky, 2018. "The evolving response to antibiotic resistance (1945–2018)," Palgrave Communications, Palgrave Macmillan, vol. 4(1), pages 1-8, December.
  • Handle: RePEc:pal:palcom:v:4:y:2018:i:1:d:10.1057_s41599-018-0181-x
    DOI: 10.1057/s41599-018-0181-x
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1057/s41599-018-0181-x
    File Function: Abstract
    Download Restriction: Access to full text is restricted to subscribers.

    File URL: https://libkey.io/10.1057/s41599-018-0181-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Olivia Hawkins & Anna Mae Scott & Amy Montgomery & Bevan Nicholas & Judy Mullan & Antoine van Oijen & Chris Degeling, 2022. "Comparing public attitudes, knowledge, beliefs and behaviours towards antibiotics and antimicrobial resistance in Australia, United Kingdom, and Sweden (2010-2021): A systematic review, meta-analysis,," PLOS ONE, Public Library of Science, vol. 17(1), pages 1-26, January.
    2. Nicolas Fortané, 2021. "Antimicrobial resistance: preventive approaches to the rescue? Professional expertise and business model of French “industrial” veterinarians," Review of Agricultural, Food and Environmental Studies, Springer, vol. 102(2), pages 213-238, June.
    3. Lenore Manderson, 2020. "Prescribing, care and resistance: antibiotic use in urban South Africa," Palgrave Communications, Palgrave Macmillan, vol. 7(1), pages 1-10, December.
    4. Claas Kirchhelle, 2023. "The Antibiocene – towards an eco-social analysis of humanity’s antimicrobial footprint," Palgrave Communications, Palgrave Macmillan, vol. 10(1), pages 1-12, December.
    5. Fortané, Nicolas, 2020. "Antimicrobial resistance: preventive approaches to the rescue? Professional expertise and business model of French “industrial” veterinarians," Review of Agricultural, Food and Environmental Studies, Institut National de la Recherche Agronomique (INRA), vol. 102(1), January.
    6. Adam Hannah & Erik Baekkeskov, 2020. "The promises and pitfalls of polysemic ideas: ‘One Health’ and antimicrobial resistance policy in Australia and the UK," Policy Sciences, Springer;Society of Policy Sciences, vol. 53(3), pages 437-452, September.
    7. Charlotte Brives & Jessica Pourraz, 2020. "Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures," Palgrave Communications, Palgrave Macmillan, vol. 6(1), pages 1-11, December.
    8. Clare I. R. Chandler, 2019. "Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure," Palgrave Communications, Palgrave Macmillan, vol. 5(1), pages 1-13, December.
    9. Gabriel K. Innes & Agnes Markos & Kathryn R. Dalton & Caitlin A. Gould & Keeve E. Nachman & Jessica Fanzo & Anne Barnhill & Shannon Frattaroli & Meghan F. Davis, 2021. "How animal agriculture stakeholders define, perceive, and are impacted by antimicrobial resistance: challenging the Wellcome Trust’s Reframing Resistance principles," Agriculture and Human Values, Springer;The Agriculture, Food, & Human Values Society (AFHVS), vol. 38(4), pages 893-909, December.
    10. Hannah Landecker, 2019. "Antimicrobials before antibiotics: war, peace, and disinfectants," Palgrave Communications, Palgrave Macmillan, vol. 5(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:palcom:v:4:y:2018:i:1:d:10.1057_s41599-018-0181-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: https://www.nature.com/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.